Early detection is crucial in the fight against canine cancer. DeepScan's innovative cancer screening test uses cutting-edge technology to detect circulating free DNA (cfDNA), offering a non-invasive way to identify potential cancer in dogs before symptoms appear. This test represents a significant advancement in veterinary oncology, bringing the power of liquid biopsy technology to canine cancer detection.
Circulating free DNA (cfDNA) refers to fragments of DNA found in the bloodstream. These fragments can come from various sources, including:
When cancer is present, tumor cells release their DNA into the bloodstream at a higher rate than normal cells. This tumor-derived cfDNA can provide valuable information about the presence and nature of cancer in the body.
DeepScan's cancer screening test for dogs involves several steps:
"cfDNA analysis is revolutionizing how we approach cancer detection in veterinary medicine, offering a minimally invasive way to catch cancer early."
It's important to understand that a positive result doesn't necessarily mean your dog has cancer. It indicates that cancer-associated genetic alterations were detected, warranting further investigation. Your veterinarian may recommend additional tests to confirm a diagnosis.
Conversely, a negative result doesn't guarantee that your dog is cancer-free. Regular check-ups and being aware of cancer warning signs remain crucial.
While beneficial for many dogs, DeepScan's cfDNA testing may be particularly valuable for:
Research in cfDNA analysis is ongoing, with potential future developments including:
DeepScan's test stands out for its consideration of breed-specific factors. The company has conducted extensive research to establish baseline cfDNA profiles for different dog breeds, potentially improving the test's accuracy across various breeds and cancer types.
DeepScan is committed to rigorous scientific validation of their test. The company has conducted studies involving thousands of dogs across multiple European countries, including both healthy dogs and those with cancer diagnoses. Additionally, a long-term follow-up study is underway to further evaluate the test's effectiveness in detecting early-stage cancers in high-risk breeds.
By understanding how DeepScan's cancer screening test works to detect cfDNA, you can make informed decisions about your dog's health care. This advanced technology, combined with other preventive measures, offers a promising new tool for the early detection and management of canine cancer.
.png)
